Showing results (1681-1690 of 1,823) with videos related to

Sort By:
Pageof 183
British Journal of Haematology|April 2, 2015
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomasFelipe Samaniego, Fredrick Hagemeister, Jorge E Romaguera, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2025
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory LymphomaFelipe Soto, Ugochi Ebinama, William P Brasher, et al.
The Lancet. Oncology|September 16, 2021
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgeryJoe Y Chang, Reza J Mehran, Lei Feng, et al.
Translational Psychiatry|February 19, 2020
Mindfulness improves inflammatory biomarker levels in older adults with mild cognitive impairment: a randomized controlled trialTed Kheng Siang Ng, Johnson Fam, Lei Feng, et al.
Molecular and Cellular Biochemistry|September 9, 2008
Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanismsHai-Feng Ou-Yang, Hong-Wei Zhang, Chang-Gui Wu, et al.
Molecular and Cellular Biochemistry|September 13, 2007
Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cellsXue-Ping Zhang, Gang Zheng, Lian Zou, et al.
Medicine|October 28, 2024
Positive association between constipation and mild cognitive impairment in elders: A cross-sectional studyKai-Yong Huang, Zhen-Zhen Yu, Jia-Jun Tu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 9, 2018
Scalp blocks for brain tumor craniotomies: A retrospective survival analysis of a propensity match cohort of patientsJuan P Cata, Shreyas Bhavsar, Katherine B Hagan, et al.
Cancer Science|March 30, 2011
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppressionYong-Mei Yang, A-Lei Feng, Cheng-Jun Zhou, et al.
Eclinicalmedicine|August 20, 2024
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trialAshwath Gurumurthi, Collin K Chin, Lei Feng, et al.
Pageof 183